DRUG | SUPPLIED | DOSE | COMMENTS |
---|---|---|---|
EPINEPHRINE MDI (Paeds) (Primatene) Mechanism of action: Alpha and beta adrenergic agonist, vasoconstrictor. Ref: 126, 159, 541 Last update: 2021-07-20 |
Metered Dose Inhaler (MDI): 125 mcg/puff | ED/PICU/ Infant Transport Team (in the field): Maximum: 15 puffs in 60 minutes |
Product not licensed in Canada, use is for croup in COVID-19 pandemic in place of nebulized epinephrine only at BCCH in the ED and PICU or by ITT under the advice of a physician at BCCH. MDI to be used with a patient appropriated sized spacer device. Effectiveness - Westley Croup Score (LOC, cyanosis, stridor, air entry, retractions) before and after each set of inhalations. Safety - continuous pulse oximetry and cardiorespiratory monitoring. Adverse effects: tachycardia, increased BP, pallor, jitteriness. Standard Prescription: Epinephrine MDI __ puffs q10 mins PRN through spacer. (Maximum: 15 puffs in 60 minutes) |